A case of duodenal ulcer as prominent manifestation of IgG4-related disease

  • Min FENG ,
  • Zhe CHEN ,
  • Yong-jing CHENG
Expand
  • Department of Rheumatology, Beijing Hospital; National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China

Received date: 2023-08-22

  Online published: 2023-12-11

Abstract

A case of IgG4-related disease presented with a duodenal ulcer to improve the understan-ding of IgG4-related diseases was reported. A 70-year-old male presented with cutaneous pruritus and abdominal pain for four years and blackened stools for two months. Four years ago, the patient went to hospital for cutaneous pruritus and abdominal pain. Serum IgG4 was 3.09 g/L (reference value 0-1.35 g/L), alanine aminotransferase 554 U/L (reference value 9-40 U/L), aspartate aminotransferase 288 U/L (reference value 5-40 U/L), total bilirubin 54.16 μmol/L (reference value 2-21 μmol/L), and direct bilirubin 29.64 μmol/L (reference value 1.7-8.1 μmol/L) were all elevated. The abdominal CT scan and magnetic resonance cholangiopancreatography indicated pancreatic swelling, common bile duct stenosis, and secondary obstructive dilation of the biliary system. The patient was diagnosed with IgG4-related disease and treated with prednisone at 40 mg daily. As jaundice and abdominal pain improved, prednisone was gradually reduced to medication discontinuation. Two months ago, the patient developed melena, whose blood routine test showed severe anemia, and gastrointestinal bleeding was diagnosed. The patient came to the emergency department of Beijing Hospital with no improvement after treatment in other hospitals. Gastroscopy revealed a 1.5 cm firm duodenal bulb ulcer. After treatment with omeprazole, the fecal occult blood was still positive. The PET-CT examination was performed, and it revealed no abnormality in the metabolic activity of the duodenal wall, and no neoplastic lesions were found. IgG4-related disease was considered, and the patient was admitted to the Department of Rheumatology and Immunology of Beijing Hospital for further diagnosis and treatment. The patient had a right submandibular gland mass resection history and diabetes mellitus. After the patient was admitted to the hospital, the blood test was reevaluated. The serum IgG4 was elevated at 5.44 g/L (reference value 0.03-2.01 g/L). Enhanced CT of the abdomen showed that the pancreas was mild swelling and was abnormally strengthened, with intrahepatic and extrahepatic bile duct dilation and soft tissue around the superior mesenteric vessels. We pathologically reevaluated and stained biopsy specimens of duodenal bulbs for IgG and IgG4. Immunohistochemical staining revealed remarkable infiltration of IgG4-positive plasma cells into duodenal tissue, the number of IgG4-positive cells was 20-30 cells per high-powered field, and the ratio of IgG4/IgG-positive plasma cells was more than 40%. The patient was treated with intravenous methylprednisolone at 40 mg daily dosage and cyclophosphamide, and then the duodenal ulcer was healed. IgG4 related disease is an immune-medicated rare disease characterized by chronic inflammation and fibrosis. It is a systemic disease that affects nearly every anatomic site of the body, usually involving multiple organs and diverse clinical manifestations. The digestive system manifestations of IgG4-related disease are mostly acute pancreatitis and cholangitis and rarely manifest as gastrointestinal ulcers. This case confirms that IgG4-related disease can present as a duodenal ulcer and is one of the rare causes of duodenal ulcers.

Cite this article

Min FENG , Zhe CHEN , Yong-jing CHENG . A case of duodenal ulcer as prominent manifestation of IgG4-related disease[J]. Journal of Peking University(Health Sciences), 2023 , 55(6) : 1125 -1129 . DOI: 10.19723/j.issn.1671-167X.2023.06.026

References

1 L?hr JM , Vujasinovic M , Rosendahl J , et al. IgG4-related diseases of the digestive tract[J]. Nat Rev Gastroenterol Hepatol, 2022, 19 (3): 185- 197.
2 Padniewski JJ , Thottam E , Nasr R . IgG4 sclerosing disease of the esophagus: A case-based review[J]. Rheumatol Int, 2020, 40 (10): 1733- 1737.
3 Koizumi S , Kamisawa T , Kuruma S , et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases?[J]. World J Gastroenterol, 2013, 19 (35): 5769- 5774.
4 Ramakrishna B , Yewale R , Vijayakumar K , et al. Gastric IgG4-related disease presenting as a mass lesion and masquerading as a gastrointestinal stromal tumor[J]. J Pathol Transl Med, 2020, 54 (3): 258- 262.
5 Kuran S , Parlak E , Oguz D , et al. Endoscopic sphincterotomy-induced hemorrhage: Treatment with heat probe[J]. Gastrointest Endosc, 2006, 63 (3): 506- 511.
6 Yang L , Jin P , Sheng JQ . Immunoglobulin G4-related disease (IgG4-RD) affecting the esophagus, stomach, and liver[J]. Endoscopy, 2015, 47 (Suppl 1): 96- 97.
7 Khan S , Zhu LP , Jiang K , et al. Immunoglobulin G4-related disease manifesting as isolated, typical, and nontypical gastroesophageal lesion: A research of literature review[J]. Digestion, 2020, 101 (5): 506- 521.
8 Zhang X , Jin X , Guan L , et al. IgG4-related disease with gastrointestinal involvement: Case reports and literature review[J]. Front Immunol, 2022, 10 (13): 816- 830.
9 Shinji A , Sano K , Hamamo H , et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration[J]. Gastrointest Endosc, 2004, 59 (4): 506- 511.
10 Chang MC , Chang YT , Wei SC , et al. Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of helicobacter pylori infection status[J]. Pancreas, 2009, 38 (4): 442- 446.
11 Fujita T , Ando T , Sakakibara M , et al. Refractory gastric ulcer with abundant IgG4-positive plasma cell infiltration: A case report[J]. World J Gastroenterol, 2010, 16 (17): 2183- 2186.
12 Basteman AC , Sommerlad M , Underwood TJ . Chronic gastric ulceration: A novel manifestation of IgG4-related disease?[J]. J Clin Pathol, 2012, 65 (6): 569- 570.
13 Umehara H , Okazaki K , Kawa S , et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD[J]. Mod Rheumatol, 2021, 31 (3): 529- 553.
14 Lanzillotta M , Mancuso G , Della-Torre E . Advances in the diagnosis and management of IgG4 related disease[J]. BMJ, 2020, 369, m1067.
15 Maritati F , Peyronel F , Vaglio A . IgG4-related disease: A clinical perspective[J]. Rheumatology (Oxford), 2020, 59 (Suppl 3): 123- 131.
16 Sawada H , Czech T , Silangcruz K , et al. Clinicopathological characteristics of gastric IgG4-related disease: Systematic scoping review[J]. J Gastroenterol Hepatol, 2022, 37 (10): 1865- 1872.
Outlines

/